<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:36:27Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2837148" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:2837148</identifier><datestamp>2010-03-31</datestamp><setSpec>elsevierwt</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Immunol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Mol. Immunol</journal-id>
      <journal-title-group>
        <journal-title>Molecular Immunology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0161-5890</issn>
      <issn pub-type="epub">1872-9142</issn>
      <publisher>
        <publisher-name>Pergamon Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC2837148</article-id>
      <article-id pub-id-type="pmcid">PMC2837148</article-id>
      <article-id pub-id-type="pmc-uid">2837148</article-id>
      <article-id pub-id-type="pmid">20097424</article-id>
      <article-id pub-id-type="publisher-id">S0161-5890(09)00889-X</article-id>
      <article-id pub-id-type="doi">10.1016/j.molimm.2009.12.016</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>C-type lectin Langerin is a Î²-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>de Jong</surname>
            <given-names>Marein A.W.P.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vriend</surname>
            <given-names>Lianne E.M.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Theelen</surname>
            <given-names>Bart</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Taylor</surname>
            <given-names>Maureen E.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">d</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fluitsma</surname>
            <given-names>Donna</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Boekhout</surname>
            <given-names>Teun</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Geijtenbeek</surname>
            <given-names>Teunis B.H.</given-names>
          </name>
          <email>T.B.Geijtenbeek@amc.uva.nl</email>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="cor1" ref-type="corresp">â</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands</aff>
      <aff id="aff2"><label>b</label>Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands</aff>
      <aff id="aff3"><label>c</label>CBS Fungal Diversity Center, Utrecht, The Netherlands</aff>
      <aff id="aff4"><label>d</label>Division of Molecular Biosciences, Department of Life Sciences, Imperial College, London, UK</aff>
      <author-notes>
        <corresp id="cor1"><label>â</label>Corresponding author. Tel.: +31 205666309. <email>T.B.Geijtenbeek@amc.uva.nl</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>1</day>
        <month>3</month>
        <year>2010</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2010</year>
      </pub-date>
      <volume>47</volume>
      <issue>6</issue>
      <fpage>1216</fpage>
      <lpage>1225</lpage>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>12</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>22</day>
          <month>12</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>12</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2010 Elsevier Ltd.</copyright-statement>
        <copyright-year>2009</copyright-year>
        <copyright-holder>Elsevier Ltd</copyright-holder>
        <license xlink:href="https://creativecommons.org/licenses/by/3.0/">
          <license-p>Open Access under <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/3.0/">CC BY 3.0</ext-link> license</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Langerhans cells (LCs) lining the stratified epithelia and mucosal tissues are the first antigen presenting cells to encounter invading pathogens, such as viruses, bacteria and fungi. Fungal infections form a health threat especially in immuno-compromised individuals. LCs express C-type lectin Langerin that has specificity for mannose, fucose and GlcNAc structures. Little is known about the role of human Langerin in fungal infections. Our data show that Langerin interacts with both mannan and Î²-glucan structures, common cell-wall carbohydrate structures of fungi. We have screened a large panel of fungi for recognition by human Langerin and, strikingly, we observed strong binding of Langerin to a variety of <italic>Candida</italic> and <italic>Saccharomyces</italic> species and <italic>Malassezia furfur</italic>, but very weak binding was observed to <italic>Cryptococcus gattii</italic> and <italic>Cryptococcus neoformans</italic>. Notably, Langerin is the primary fungal receptor on LCs, since the interaction of LCs with the different fungi was blocked by antibodies against Langerin. Langerin recognizes both mannose and Î²-glucans present on fungal cell walls and our data demonstrate that Langerin is the major fungal pathogen receptor on human LCs that recognizes pathogenic and commensal fungi. Together these data may provide more insight in the role of LCs in fungal infections.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Î²-Glucan</kwd>
        <kwd>C-type lectin</kwd>
        <kwd>Fungi</kwd>
        <kwd>Langerhans cells</kwd>
        <kwd>Langerin</kwd>
        <kwd>Yeast</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <label>1</label>
      <title>Introduction</title>
      <p>Langerin (CD207) is a C-type lectin expressed in human exclusively by Langerhans cells (LCs), which constitute a subset of dendritic cells that are located in epithelium of mucosal tissues and epidermis (<xref rid="bib15 bib28" ref-type="bibr">Fithian et al., 1981; Patterson et al., 2002</xref>). LCs play a key role in the induction of immune responses against invading pathogens by capturing and processing foreign antigens and migrating to draining lymph nodes to present processed antigens to T cells (<xref rid="bib3" ref-type="bibr">Banchereau and Steinman, 1998</xref>). As a C-type lectin, Langerin is thought to play a role in pathogen recognition by facilitating pathogen uptake and processing for antigen presentation (<xref rid="bib20" ref-type="bibr">Hunger et al., 2004</xref>). Langerin is a type II transmembrane protein that contains one calcium-dependent carbohydrate recognition domain with a short cytoplasmic tail with a proline rich motif (<xref rid="bib36" ref-type="bibr">Valladeau et al., 2003</xref>). Langerin forms a trimer on the cell surface and upon crosslinking with either a cell-bound or a soluble ligand, Langerin induces the formation of Birbeck granules, which are LC-specific intracellular organelles that appear as tennis-racket like structures with a size of &lt;1Â Î¼m in diameter that are thought to be part of the endosomal recycling pathway (<xref rid="bib35" ref-type="bibr">Valladeau et al., 2000</xref>).</p>
      <p>Although Langerin is characterized as a pathogen recognition receptor, only few pathogens have been demonstrated to interact with Langerin. Both HIV-1 (<xref rid="bib13 bib34" ref-type="bibr">de Witte et al., 2007; Turville et al., 2001</xref>) and <italic>Mycobacteria leprae</italic> (<xref rid="bib20" ref-type="bibr">Hunger et al., 2004</xref>) have been identified as pathogens that interact with human Langerin, whereas murine Langerin was shown to bind to <italic>Candida albicans</italic> (<xref rid="bib32 bib33" ref-type="bibr">Takahara et al., 2002, 2004</xref>). Langerin is important in protecting against HIV-1 transmission, since HIV-1 captured by Langerin is rapidly internalized into Birbeck granules for degradation, thereby preventing HIV-1 infection of LCs (<xref rid="bib13 bib34" ref-type="bibr">de Witte et al., 2007; Turville et al., 2001</xref>). Based on the carbohydrate recognition specificity for mannose, fucose and N-acetyl-glucosamine monosaccharides (GlcNAc) (<xref rid="bib31" ref-type="bibr">Stambach and Taylor, 2003</xref>), it is likely that Langerin has a broader specificity for pathogens than has been identified so far.</p>
      <p>Fungal species are ubiquitous residents of human skin and many can cause invasive infections especially in immuno-compromised individuals. They can be acquired from the environment, such as <italic>Cryptococcus neoformans</italic>, or are part of the normal skin microbiota, such as <italic>Candida albicans</italic> (<xref rid="bib29" ref-type="bibr">Richardson, 2005</xref>) or <italic>Malassezia</italic> species (<xref rid="bib4 bib19" ref-type="bibr">Batra et al., 2005; Gupta et al., 2004</xref>). The close contact of the fungi with the epidermis and epithelial barrier suggests that LCs might be involved in fungal defense. Therefore we have investigated the interaction of a panel of fungi with Langerin on LCs.</p>
      <p>Fungi, such as <italic>Candida</italic> species ubiquitously express Î²-glucans and mannosylated carbohydrate structures in their cell wall (<xref rid="bib11 bib16" ref-type="bibr">Chaffin et al., 1998; Gantner et al., 2005</xref>). Here we demonstrate that Langerin not only recognizes mannose, fucose and GlcNAc structures, but also Î²-glucan structures. To our knowledge, thus far dectin-1 is the only C-type lectin in human that has been associated with Î²-glucan binding (<xref rid="bib9 bib8" ref-type="bibr">Brown et al., 2003; Brown and Gordon, 2001</xref>). Here, we demonstrate that aside from dectin-1, Langerin also interacts with Î²-glucans, which can possibly mediate recognition of fungi and bacteria to initiate an anti-microbial response.</p>
      <p>In addition, we demonstrate that Langerin is a receptor for <italic>Candida</italic> species, <italic>Saccharomyces</italic> species and <italic>Malassezia furfur</italic>, but only weakly interacts with <italic>Cryptococcus gattii</italic> and <italic>Cryptococcus neoformans</italic>. Our data further show that Langerin is the main C-type lectin receptor for fungi on primary human LCs even though these also express dectin-1. Thus, we have demonstrated that Langerin on LCs is a pathogen recognition receptor for Î²-glucans and a broad range of fungi. Increased knowledge of the pathogen recognition profile by Langerin on LCs can contribute to the understanding of the pathogenicity of fungi.</p>
    </sec>
    <sec sec-type="results">
      <label>2</label>
      <title>Results</title>
      <sec>
        <label>2.1</label>
        <title>Langerin recognizes <italic>Candida</italic>, <italic>Malassezia</italic> and <italic>Saccharomyces</italic> species</title>
        <p>A large panel of pathogenic fungi was screened for binding to recombinant Langerin in an ELISA system (<xref rid="tbl1" ref-type="table">Table 1</xref>). This recombinant Langerin contains the whole extracellular region including the carbohydrate recognition domain and the coiledâcoil stalk that allows oligomerization (<xref rid="bib31" ref-type="bibr">Stambach and Taylor, 2003</xref>). To determine the specificity of the binding, polysaccharide mannan was used to inhibit the C-type lectin domain. Langerin interacted strongly with all <italic>Saccharomyces</italic> species, <italic>Malassezia furfur</italic> and <italic>Candida</italic> species, including <italic>C. albicans</italic>, <italic>C. dubliensis</italic>, <italic>C. glabrata</italic>, <italic>C. guilliermondii</italic>, <italic>C. krusei</italic>, <italic>C. parapsilosis</italic>, <italic>C. tropicalis</italic>, <italic>C. lusitaniae</italic>, <italic>C. nivariensis</italic>, <italic>C. orthopsilosis</italic> and <italic>C. metapsilosis</italic> (<xref rid="fig1" ref-type="fig">Fig. 1</xref>A and B). In contrast, no or low binding was observed for <italic>Cr. neoformans</italic> varieties and <italic>Cr. gattii</italic> of different serotypes (<xref rid="fig1" ref-type="fig">Fig. 1</xref>B). The inclusion of an acapsular <italic>Cr. neoformans</italic> (CBS 7935) demonstrated that the lack of binding is not due to the capsule.</p>
        <p>To investigate the interaction between these fungi and Langerin in depth, a selection was made and a titration was performed. To determine the specificity of the Langerin binding ELISA, we investigated the ability of mannan and anti-Langerin to block the interaction of Langerin with coated ligands. Both inhibitors prevented Langerin binding to different concentrations of mannan and <italic>C. albicans</italic>, although mannan is slightly more efficient in blocking Langerin compared to anti-Langerin (<xref rid="fig1" ref-type="fig">Fig. 1</xref>C and D). In addition, both life and heat-killed <italic>C. albicans</italic> were compared and similar binding patterns were observed, demonstrating that heat-treatment did not alter the binding to Langerin (<xref rid="fig1" ref-type="fig">Fig. 1</xref>E).</p>
        <p>Langerin efficiently interacted with all <italic>Candida</italic> species tested, namely <italic>C. albicans</italic>, <italic>C. glabrata</italic>, <italic>C. guilliermondii</italic>, <italic>C. krusei</italic>, <italic>C. lusitaniae</italic>, and <italic>C. nivariensis</italic>, and <italic>Saccharomyces cerevisiae</italic> at a concentration of 10<sup>6</sup> and 10<sup>7</sup>/ml, whereas most binding was lost at 10<sup>5</sup>/ml or lower (<xref rid="fig1 fig2" ref-type="fig">Figs. 1D and 2A, B and E</xref>). No difference was observed between virulent and non-virulent strains of <italic>S. cerevisiae</italic> (<xref rid="fig2" ref-type="fig">Fig. 2</xref>E). <italic>Cryptococcus</italic> species only weakly interacted with Langerin at high concentrations which was abrogated after dilution (<xref rid="fig2" ref-type="fig">Fig. 2</xref>C and D). These data demonstrate that Langerin is a fungal receptor that interacts with <italic>Malassezia furfur</italic>, <italic>Saccharomyces</italic> and <italic>Candida</italic> species but not with <italic>Cryptococcus</italic> species.</p>
      </sec>
      <sec>
        <label>2.2</label>
        <title>Langerin binds to Î²-glucans</title>
        <p>Langerin has been shown to interact strongly with mannose, fucose and GlcNAc structures (<xref rid="fig3" ref-type="fig">Fig. 3</xref>A) (<xref rid="bib31" ref-type="bibr">Stambach and Taylor, 2003</xref>). In addition, Langerin interacts with both Lewis B and Lewis Y through terminal fucose structures, whereas it does not interact with internal fucose present in Lewis A and Lewis X (<xref rid="bib12" ref-type="bibr">de Jong et al., 2009</xref>). In general, fungal cell walls contain a large amount of mannose structures, chitin, as well as Î²(1â3) and Î²(1â6)-glucans at the inner-layer and budding scars (<xref rid="bib11" ref-type="bibr">Chaffin et al., 1998</xref>). Mannan is a major component of the mannose structures on the cell wall and also a well-known ligand for Langerin (<xref rid="bib31 bib11" ref-type="bibr">Stambach and Taylor, 2003; Chaffin et al., 1998</xref>). Therefore we investigated whether Langerin also interacts with other fungal-derived structures. Strikingly, Langerin strongly interacted with curdlan, laminarin and zymosan (<xref rid="fig3" ref-type="fig">Fig. 3</xref>B) and this binding was inhibited by both mannan and laminarin (3CâF). Both curdlan and laminarin contain large amount of Î²-glucans, while zymosan is a ghost cell derivative of <italic>S. cerevisiae</italic>, containing both mannose and Î²-glucans. It has previously been demonstrated that Î²-glucans partially inhibit zymosan binding to mouse Langerin, which suggests a role for Langerin in Î²-glucan binding (<xref rid="bib33" ref-type="bibr">Takahara et al., 2004</xref>). Here, we demonstrate that Langerin directly interacts with Î²-glucans. These data demonstrate that Langerin recognizes also Î²-glucans, which could facilitate recognition of fungi.</p>
      </sec>
      <sec>
        <label>2.3</label>
        <title>Cellular Langerin interacts with <italic>Candida</italic> species and Zymosan but not with <italic>Cryptococcus</italic> species</title>
        <p>Next, we investigated whether a selection of this panel also interacted with cellular Langerin. Fluorescently labelled <italic>C. albicans</italic>, <italic>C. krusei</italic>, <italic>Cr. neoformans</italic>, <italic>Cr. gattii</italic>, and zymosan were incubated with a Langerin transduced cell-line, or a mock transduced cell-line. We selected the Jurkat T cell cell-line since it does not express dectin-1, which has been identified as a primary receptor for Î²-glucans (<xref rid="fig4" ref-type="fig">Fig. 4</xref>A). <italic>C. albicans</italic>, <italic>C. krusei</italic> and zymosan strongly interacted with Langerin transduced cells, which was completely inhibited by mannan, whereas no binding was observed to mock-transduced cells (<xref rid="fig4" ref-type="fig">Fig. 4</xref>B). In concordance with the Langerin binding ELISA, <italic>Cr. neoformans</italic> and <italic>Cr. gattii</italic> did neither interact with the Langerin transduced cells, nor with the mock-transduced cells. These data strongly suggest that Langerin recognizes <italic>Candida</italic> species but not <italic>Cryptococcus</italic> species.</p>
      </sec>
      <sec>
        <label>2.4</label>
        <title>Langerin is the primary receptor for fungi on primary Langerhans cells</title>
        <p>Opportunistic fungal infections often enter through the skin or mucosal tissues, where LCs are the predominant antigen presenting cells. Therefore, we investigated whether primary human LCs interact with different fungi. CD1a<sup>+</sup> LCs isolated from human epidermis express high levels of Langerin, low levels of dectin-1 and no DC-SIGN (<xref rid="fig5" ref-type="fig">Fig. 5</xref>A). Both DC-SIGN and dectin-1 have been shown to bind fungi through mannan and Î²-glucan structures, respectively (<xref rid="bib10 bib9" ref-type="bibr">Cambi et al., 2008; Brown et al., 2003</xref>). Primary LCs were incubated with fluorescently labelled <italic>C. albicans</italic>, <italic>C. krusei</italic>, <italic>Cr. neoformans</italic>, <italic>Cr. gattii</italic>, and zymosan and binding was measured by flow cytometry. Strikingly, LCs strongly interacted with <italic>C. albicans</italic>, <italic>C. krusei</italic>, and zymosan, but not with <italic>Cr. neoformans</italic> or <italic>Cr. gattii</italic> (<xref rid="fig5" ref-type="fig">Fig. 5</xref>B). The binding to <italic>C. albicans</italic>, <italic>C. krusei</italic>, and zymosan was primarily mediated via Langerin, since both mannan and specific antibodies against Langerin inhibited the binding to LCs (<xref rid="fig5" ref-type="fig">Fig. 5</xref>B). The blocking antibody against dectin-1 only weakly interfered with fungi binding to LCs, strongly suggesting that the contribution of dectin-1 on LCs is minor. <italic>Cr. neoformans</italic> and <italic>Cr. gattii</italic> failed to interact with LCs even at very high concentrations (data not shown). We observed a background binding of approximately 10%, which could be due to other receptors, such as complement receptor 3 expressed in low levels by LCs (<xref rid="bib14 bib25" ref-type="bibr">Depanfilis et al., 1990; Netea et al., 2008</xref>).</p>
        <p>Next, we have used electron microscopy to investigate the uptake of <italic>C. albicans</italic> by LCs. LCs are able to phagocytose <italic>C. albicans</italic> (<xref rid="fig6" ref-type="fig">Fig. 6</xref>A), but we also observed <italic>C. albicans</italic> at the cell surface (<xref rid="fig6" ref-type="fig">Fig. 6</xref>). Notably, Langerin was regularly localized at the interface of the cell surface and <italic>C. albicans</italic>, either when phagocytosed or cell-bound (<xref rid="fig6" ref-type="fig">Fig. 6</xref>BâD). Irregular and detached cell wall was due to the EM preparation procedure. Thus, on LCs Langerin is the primary receptor for fungi such as <italic>C. albicans</italic> and the interaction can lead to phagocytosis of the fungi particles.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <label>3</label>
      <title>Discussion</title>
      <p>Opportunistic fungal infections are a well-known problem, especially in immuno-compromised patients, such as HIV-1 infected people and transplantation patients. With an increase in the survival of these patients, there is also an increasingly large number of patients that suffer from opportunistic fungal infections (<xref rid="bib23" ref-type="bibr">McNeil et al., 2001</xref>). <italic>Candida</italic> species, especially <italic>C. albicans</italic>, and <italic>Cryptococcus</italic> species are the most common causes of invasive fungal infections in immuno-compromised patients (<xref rid="bib26 bib27" ref-type="bibr">Pappas et al., 2001, 2003</xref>). These fungi can colonize the skin and mucosal tissues that contain LCs and this dendritic cell subset might be crucial in the defense against fungi.</p>
      <p>Our data show that Langerin is the major receptor on primary LCs for <italic>Candida</italic> species, <italic>Saccharomyces</italic> species, and <italic>Malassezia furfur</italic>. Notably, we did not observe any interaction of LCs with <italic>Cryptococcus</italic> species, suggesting that this pathogenic fungus is evading immune recognition by LCs.</p>
      <p>Although <italic>C. albicans</italic> is still the leading cause of candidiasis, infections with variants such as <italic>C. parapsilosis</italic> and <italic>C. glabrata</italic> are increasingly common (<xref rid="bib1 bib2" ref-type="bibr">Almirante et al., 2005; Arendrup et al., 2008</xref>). The cell wall of <italic>Candida</italic> species consists of mannose structures (mannan), chitins (GlcNAc structures) and Î²-1,3- and Î²-1,6-glucose polymers (Î²-glucans). The mannan components are present on the outer cell layer, whereas chitins and Î²-glucans are the structural components of the wall and exposed at budding scars (<xref rid="bib21" ref-type="bibr">Karkowska-Kuleta et al., 2009</xref>). The C-type lectins dectin-1 and DC-SIGN are known fungal receptors that recognize fungi through Î²-glucan and mannan structures, respectively (<xref rid="bib10" ref-type="bibr">Cambi et al., 2008</xref>). Here we demonstrate that Langerin is also a fungal receptor that interacts with a large variety of <italic>Candida</italic> species including <italic>C. albicans</italic>, <italic>C. parapsilosis</italic>, <italic>C. glabrata</italic>, <italic>C. krusei</italic>, <italic>C. nivariensis</italic>, <italic>C. lusitaniae</italic> and more. This suggests that <italic>Candida</italic> species express conserved structures that interact with Langerin. Strikingly, we observed that Langerin does not only recognizes mannose structures on fungi but also Î²1,3-glucan structures. Currently, dectin-1 is the main C-type lectin that specifically interacts with Î²-glucans and interaction of dectin-1 on macrophages and dendritic cells with <italic>C. albicans</italic> can modulate immune responses (<xref rid="bib7" ref-type="bibr">Brown, 2006</xref>). Here, we demonstrate that Langerin also has affinity for Î²-glucans and that on human primary LCs, Langerin accounts for the majority of the interaction of <italic>Candida</italic> species. Together these data show that Langerin shares carbohydrate specificities with both DC-SIGN and dectin-1 (<xref rid="bib37 bib7" ref-type="bibr">van Kooyk and Geijtenbeek, 2003; Brown, 2006</xref>).</p>
      <p>The signalling pathways for dectin-1 and DC-SIGN have been largely identified and dectin-1 plays a central role in the defense against fungal infections (<xref rid="bib7 bib17" ref-type="bibr">Brown, 2006; Geijtenbeek and Gringhuis, 2009</xref>). Since dectin-1 appears to play a minor role in the binding of <italic>C. albicans</italic> to LCs, and Langerin interaction is more prominent, it is of great interest to investigate the immunological consequences of Langerin binding to fungi. Using electron microscopy we observed co-localization of Langerin with <italic>C. albicans</italic>. We have previously demonstrated that interaction of viruses such as HIV-1 and Langerin can lead to internalization in Langerin positive Birbeck granules (<xref rid="bib13" ref-type="bibr">de Witte et al., 2007</xref>). Due to the large size of <italic>C. albicans</italic> it seems unlikely that <italic>C. albicans</italic> can be internalized efficiently into Birbeck granules. However, our data demonstrate that LCs phagocytose fungi albeit not very efficiently. Questions remain whether Langerin is able to capture and degrade fungal pathogens in a similar manner as it is capable of degrading HIV-1. Noteworthy, we did observe that <italic>C. albicans</italic> but not <italic>Cryptococcus</italic> species could prevent the binding of HIV-1 to Langerin (data not shown), suggesting this could interfere with the protective barrier provides by Langerin on LCs and facilitate HIV-1 infection of LCs (<xref rid="bib13" ref-type="bibr">de Witte et al., 2007</xref>). However, this remains to be further determined.</p>
      <p><italic>S. cerevisiae</italic> is one of the most well-studied yeast and shows high similarity to <italic>C. albicans</italic>â cell-wall architecture (<xref rid="bib21" ref-type="bibr">Karkowska-Kuleta et al., 2009</xref>). Indeed, similar to <italic>C. albicans</italic>, <italic>S. cerevisiae</italic> strongly interacted with Langerin. In addition, we observed comparable binding the non-virulent genome-sequenced strain of <italic>S. cerevisiae</italic> and a virulent strain. These data suggest that Langerin binding does not account for the differences in virulence.</p>
      <p><italic>Malassezia</italic> species are present as normal skin flora, however they are also associated with several skin diseases such as seborrehic dermatisis, atopic dermatitis, pityriasis versicolor and Malassezia folliculitis (<xref rid="bib4 bib19" ref-type="bibr">Batra et al., 2005; Gupta et al., 2004</xref>). Most <italic>Malassezia</italic> species are lipid dependent (<xref rid="bib39" ref-type="bibr">Xu et al., 2007</xref>), while one species, <italic>M. pachydermatis</italic>, is lipophilic and their cell wall is relatively thick (<xref rid="bib24" ref-type="bibr">Mittag, 1995</xref>). Recently, it was demonstrated that <italic>Malassezia</italic> species have low mannose content in the cell wall, but strikingly <italic>Malassezia</italic> species reacted with anti-Î²-1,3-glucan antibody (<xref rid="bib30" ref-type="bibr">Shibata et al., 2009</xref>). Here, we demonstrate that Langerin interacts with <italic>M. furfur</italic> and this suggests that the interaction is mediated via Î²-glucan structures. <italic>M. furfur</italic> and <italic>M. pachydermatis</italic> recently been identified as an activating ligand for C-type lectin Mincle (<xref rid="bib40" ref-type="bibr">Yamasaki et al., 2009</xref>). Notably, we did not observe binding of Langerin to <italic>M. pachydermatis</italic> (data not shown). No difference in galactomannan spectra was observed by <xref rid="bib30" ref-type="bibr">Shibata et al. (2009)</xref>, however <italic>M. pachydermatis</italic> is a single non-lipid dependent species, which might account for the difference in binding to Langerin because of differences in cell-wall composition.</p>
      <p><italic>Cryptococcus</italic> species <italic>Cr. neoformans</italic>, which has a predilection for the central nervous system and is highly prevalent in HIV-1 infected patients, and <italic>Cr. gattii</italic>, which can cause infections in immune-competent patients, did not interact with Langerin. Although it has been described that the capsule of <italic>Cr. neoformans</italic> determines its virulence and allows immune escape by circumventing recognition by antigen presenting cells (<xref rid="bib38 bib22" ref-type="bibr">Vecchiarelli et al., 2003; Kozubowski et al., 2009</xref>), binding by Langerin was not rescued using an acapsular variant. These data suggest that underneath the capsule, no carbohydrate structures are present that are recognized by Langerin. It remains to be determined whether acapsular <italic>Cr. neoformans</italic> can elicit proper immune response in LCs.</p>
      <p>In this screening of opportunistic and pathogenic fungi interaction with Langerin and LCs we demonstrate that Langerin is a receptor for <italic>Candida</italic> species, <italic>Saccharomyces</italic> species and <italic>Malassezia furfur</italic> and we have shown that Langerin is a Î²-glucan receptor. This knowledge strongly suggests that Langerin is an important fungal receptor on LCs. It remains to be determined whether the binding is mediated via mannose structures or Î²-glucans present on fungi. Moreover, future studies are necessary to further examine the immunological consequences of these fungal interactions with Langerin on LCs and how this can contribute to the pathogenicity of fungal infections.</p>
    </sec>
    <sec sec-type="materials|methods">
      <label>4</label>
      <title>Materials and methods</title>
      <sec>
        <label>4.1</label>
        <title>Antibodies and reagents</title>
        <p>The following antibodies and reagents were used: CD1a-FITC, Langerin-PE, DCGM4 (anti-Langerin) (all Immunotech), goat anti-mouse-FITC (Zymed Laboratories Inc.), isotype control IgG1 and IgG2b, anti dectin-1 (259931), and polyclonal anti-Langerin (all R&amp;D systems), AZN-D1 (anti-DC-SIGN) (<xref rid="bib18" ref-type="bibr">Geijtenbeek et al., 2000</xref>), 10E2 (anti-Langerin) (<xref rid="bib13" ref-type="bibr">de Witte et al., 2007</xref>). Mannan from <italic>S. cerevisiae</italic>, curdlan from <italic>Alcaligenes faecalis</italic>, laminarin from <italic>Laminaria digitata</italic>, zymosan from <italic>S. cerevisiae</italic> (all SigmaâAldrich), and zymosan-FITC (Molecular probes). Biotinylated polyacrylamide (PAA)-coupled glycoconjucates Mannose, Fucose, GlcNAc (N-acetyl-glucoseamine), GalNAc (N-acetyl-galactoseamine), Lewis (Le)X (GalÎ²1-4(FucÎ±1-3)GlcNAc), LeY (FucÎ±1-2GalÎ²1-4(FucÎ±1-3)GlcNAc), LeA (GalÎ²1-4(FucÎ±1-3)GlcNAc), LeB (FucÎ±1-2GalÎ²1-4(FucÎ±1-3)GlcNAc) were obtained from Lectinity. The following buffers were used: TSM buffer: Tris buffer (20Â mM TrisâHCl, pH 7, 150Â mM NaCl, 1Â mM CaCl<sub>2</sub>, 2Â mM MgCl<sub>2</sub>) (TSM), TSA buffer: TSM supplemented with BSA. PBA buffer: PBS supplemented with 0.5% BSA and 0.02% Azide.</p>
      </sec>
      <sec>
        <label>4.2</label>
        <title>Yeast preparation</title>
        <p>Yeast strains were obtained from CBS Fungal Biodiversity Centre (<ext-link ext-link-type="uri" xlink:href="http://www.cbs.knaw.nl/">www.cbs.knaw.nl</ext-link>) and included some new hybrid strains (<xref rid="bib5 bib6" ref-type="bibr">Bovers et al., 2006, 2008</xref>). Yeast strains were cultured for 3 days at 25Â Â°C on YPGA medium followed by inoculation in Sabouraud dextrose broth and incubated at 25Â Â°C for 3 days, while shaking.</p>
        <p><italic>Malassezia</italic> strains were cultured on solid mLNA medium for 3 days at 30Â Â°C. Yeast strains were harvested and heat inactivated for 1Â h at 56Â Â°C. Optical density measurement at 600Â nm was used to determine the concentration. Yeast strains were washed extensively in PBS before storage at â20Â Â°C at a concentration of 5Â ÃÂ 10<sup>8</sup>/ml until use.</p>
      </sec>
      <sec>
        <label>4.3</label>
        <title>Cell-lines and LC isolation</title>
        <p>Jurkat and Jurkat-Langerin transduced cells were produced as described previously and were cultured in RPMI medium with 10% FCS (<xref rid="bib35 bib13" ref-type="bibr">Valladeau et al., 2000; de Witte et al., 2007</xref>).</p>
        <p>To isolate human LCs, human tissue was obtained from healthy donors undergoing corrective breast or abdominal surgery after informed consent in accordance with institutional guidelines and used within 3Â h after surgery. The skin is cut in 0.3Â mm slices containing the dermis and epidermis and incubated overnight at 4Â Â°C in dispase II (1Â mg/ml, Roche diagnostics) in Iscoves Modified Dulbecco's medium (IMDM) and gentamycin (10Â Î¼g/ml) overnight. The epidermis was mechanically separated and cultured in IMDM, 10% FCS, gentamycin (10Â Î¼g/ml), GM-CSF (800Â U/ml) and IL-4 (800Â U/ml). After 3 days the cells were harvested and layered on a ficoll density gradient to obtaining a 90% pure LC population as determined by flow cytometry and used immediately (<xref rid="bib13" ref-type="bibr">de Witte et al., 2007</xref>).</p>
      </sec>
      <sec>
        <label>4.4</label>
        <title>Langerin binding ELISA</title>
        <p>Different fungi (10<sup>4</sup>â10<sup>7</sup>/ml), carbohydrate structures (2Â Î¼g/ml) or Î²-glucans were coated onto ELISA plates overnight at room temperature. Non-specific binding was blocked by incubating the plate with 2% TSA buffer for 1Â h at 37Â Â°C. Recombinant human Langerin (<xref rid="bib31" ref-type="bibr">Stambach and Taylor, 2003</xref>) (2Â Î¼g/ml in 2% TSA) was added for 1Â h at 37Â Â°C. Unbound Langerin was washed away and binding was determined using an anti-Langerin antibody (DCGM4, Beckman Coulter Inc.) followed by peroxidise-conjugated goat anti-mouse IgG antibody (Jackson Immunoresearch). Specificity was determined in the presence of mannan (1Â mg/ml) or anti-Langerin monoclonal antibody 10E2 (10Â Î¼g/ml) (<xref rid="bib13" ref-type="bibr">de Witte et al., 2007</xref>). Efficient coating of the different fungi was confirmed with plant-lectin binding ConA (<italic>Canavalia ensiformis</italic>).</p>
      </sec>
      <sec>
        <label>4.5</label>
        <title>Facs analysis</title>
        <p>50,000 cells (Jurkat, Jurkat-Langerin or LCs) were washed in PBA and incubated with specific antibodies (5Â Î¼g/ml) or isotype controls for 30Â min at 4Â Â°C and followed by an incubation with FITC-labelled secondary antibodies for 30Â min at 4Â Â°C, or cells were incubated with directly labelled antibodies for 30Â min at 4Â Â°C. Cells were washed and binding was measured using flow cytometry.</p>
      </sec>
      <sec>
        <label>4.6</label>
        <title>Fitc labelling</title>
        <p>Yeast strains were incubated with Fluorescein, 5â²-isothiocyanate isomer I (FITC) (Sigma) (1Â mg/ml in DMSO) for 1Â h at room temperature. Yeast strains were washed extensively in PBS to eliminate unbound FITC. The solution was resuspended at a concentration of 1Â ÃÂ 10<sup>8</sup>/ml and stored at 4Â Â°C in the dark until use.</p>
      </sec>
      <sec>
        <label>4.7</label>
        <title>Cell binding assay</title>
        <p>50,000 cells (Jurkat, Jurkat-Langerin or LCs) were washed in 0.5% TSA and pre-incubated with mannan, blocking antibodies against Langerin or dectin-1, or isotype controls for 15Â min at 37Â Â°C. Different strains of FITC-labelled yeast were added for 45Â min at 37Â Â°C. Cells were washed and binding was measured using flow cytometry. Forward-site scatter gating was used to exclude unbound yeast.</p>
      </sec>
      <sec>
        <label>4.8</label>
        <title>Electron microscopy</title>
        <p>LCs (1Â ÃÂ 10<sup>6</sup>) were incubated with 1Â ÃÂ 10<sup>7</sup>
<italic>C. albicans</italic> for 4Â h. Cells were fixed and sections were prepared according to standard protocol (<xref rid="bib13" ref-type="bibr">de Witte et al., 2007</xref>). Sections were stained for Langerin as described previously using polyclonal Langerin antibody (R&amp;D) (<xref rid="bib13" ref-type="bibr">de Witte et al., 2007</xref>).</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Almirante</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Rodriguez</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Cuenca-Estrella</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Planes</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Almela</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mensa</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ayats</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gimenez</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Saballs</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Fridkin</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rodriguez-Tudela</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Warnock</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Pahissa</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology and predictors of mortality in cases of <italic>Candida</italic> bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003</article-title>
          <source>J. Clin. Microbiol.</source>
          <volume>43</volume>
          <year>2005</year>
          <fpage>1829</fpage>
          <lpage>1835</lpage>
          <pub-id pub-id-type="pmid">15815004</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arendrup</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Fuursted</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Gahrn-Hansen</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Schonheyder</surname>
              <given-names>H.C.</given-names>
            </name>
            <name>
              <surname>Knudsen</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>I.M.</given-names>
            </name>
            <name>
              <surname>Bruun</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Christensen</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Johansen</surname>
              <given-names>H.K.</given-names>
            </name>
          </person-group>
          <article-title>Semi-national surveillance of fungaemia in Denmark 2004â2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility</article-title>
          <source>Clin. Microbiol. Infect.</source>
          <volume>14</volume>
          <year>2008</year>
          <fpage>487</fpage>
          <lpage>494</lpage>
          <pub-id pub-id-type="pmid">18294241</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banchereau</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Steinman</surname>
              <given-names>R.M.</given-names>
            </name>
          </person-group>
          <article-title>Dendritic cells and the control of immunity</article-title>
          <source>Nature</source>
          <volume>392</volume>
          <year>1998</year>
          <fpage>245</fpage>
          <lpage>252</lpage>
          <pub-id pub-id-type="pmid">9521319</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Batra</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Boekhout</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Gueho</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Cabanes</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Dawson</surname>
              <given-names>T.L.</given-names>
              <suffix>Jr.</suffix>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>A.K.</given-names>
            </name>
          </person-group>
          <article-title><italic>Malassezia Baillon</italic>, emerging clinical yeasts</article-title>
          <source>FEMS Yeast Res.</source>
          <volume>5</volume>
          <year>2005</year>
          <fpage>1101</fpage>
          <lpage>1113</lpage>
          <pub-id pub-id-type="pmid">16084129</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bovers</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hagen</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Kuramae</surname>
              <given-names>E.E.</given-names>
            </name>
            <name>
              <surname>Diaz</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Spanjaard</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Dromer</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Hoogveld</surname>
              <given-names>H.L.</given-names>
            </name>
            <name>
              <surname>Boekhout</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Unique hybrids between the fungal pathogens <italic>Cryptococcus neoformans</italic> and <italic>Cryptococcus gattii</italic></article-title>
          <source>FEMS Yeast Res.</source>
          <volume>6</volume>
          <year>2006</year>
          <fpage>599</fpage>
          <lpage>607</lpage>
          <pub-id pub-id-type="pmid">16696655</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bovers</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hagen</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Kuramae</surname>
              <given-names>E.E.</given-names>
            </name>
            <name>
              <surname>Hoogveld</surname>
              <given-names>H.L.</given-names>
            </name>
            <name>
              <surname>Dromer</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>St-Germain</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Boekhout</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>AIDS patient death caused by novel <italic>Cryptococcus neoformans</italic>Â ÃÂ <italic>C. gattii</italic> hybrid</article-title>
          <source>Emerg. Infect. Dis.</source>
          <volume>14</volume>
          <year>2008</year>
          <fpage>1105</fpage>
          <lpage>1108</lpage>
          <pub-id pub-id-type="pmid">18598632</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>G.D.</given-names>
            </name>
          </person-group>
          <article-title>Dectin-1: a signalling non-TLR pattern-recognition receptor</article-title>
          <source>Nat. Rev. Immunol.</source>
          <volume>6</volume>
          <year>2006</year>
          <fpage>33</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="pmid">16341139</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Immune recognition. A new receptor for beta-glucans</article-title>
          <source>Nature</source>
          <volume>413</volume>
          <year>2001</year>
          <fpage>36</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="pmid">11544516</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Herre</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Willment</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Dectin-1 mediates the biological effects of beta-glucans</article-title>
          <source>J. Exp. Med.</source>
          <volume>197</volume>
          <year>2003</year>
          <fpage>1119</fpage>
          <lpage>1124</lpage>
          <pub-id pub-id-type="pmid">12719478</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cambi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Netea</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Mora-Montes</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Gow</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Hato</surname>
              <given-names>S.V.</given-names>
            </name>
            <name>
              <surname>Lowman</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Kullberg</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Torensma</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Figdor</surname>
              <given-names>C.G.</given-names>
            </name>
          </person-group>
          <article-title>Dendritic cell interaction with <italic>Candida albicans</italic> critically depends on N-linked mannan</article-title>
          <source>J. Biol. Chem.</source>
          <volume>283</volume>
          <year>2008</year>
          <fpage>20590</fpage>
          <lpage>20599</lpage>
          <pub-id pub-id-type="pmid">18482990</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaffin</surname>
              <given-names>W.L.</given-names>
            </name>
            <name>
              <surname>Lopez-Ribot</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Casanova</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gozalbo</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>J.P.</given-names>
            </name>
          </person-group>
          <article-title>Cell wall and secreted proteins of <italic>Candida albicans</italic>: identification, function, and expression</article-title>
          <source>Microbiol. Mol. Biol. Rev.</source>
          <volume>62</volume>
          <year>1998</year>
          <fpage>130</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="pmid">9529890</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Jong</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>de Witte</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Santegoets</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Fluitsma</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>de Gruijl</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Geijtenbeek</surname>
              <given-names>T.B.</given-names>
            </name>
          </person-group>
          <article-title>Mutz-3-derived Langerhans cells are a model to study HIV-1 transmission and potential inhibitors</article-title>
          <source>J. Leukoc. Biol.</source>
          <volume>87</volume>
          <year>2009</year>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Witte</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Nabatov</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Pion</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fluitsma</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>de Jong</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>de Gruijl</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Piguet</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>van Kooyk</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Geijtenbeek</surname>
              <given-names>T.B.</given-names>
            </name>
          </person-group>
          <article-title>Langerin is a natural barrier to HIV-1 transmission by Langerhans cells</article-title>
          <source>Nat. Med.</source>
          <volume>13</volume>
          <year>2007</year>
          <fpage>367</fpage>
          <lpage>371</lpage>
          <pub-id pub-id-type="pmid">17334373</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Depanfilis</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Soligo</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Manara</surname>
              <given-names>G.C.</given-names>
            </name>
            <name>
              <surname>Ferrari</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Torresani</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Zucchi</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Human normal-resting epidermal langerhans cells do express the type-3 complement receptor</article-title>
          <source>Br. J. Dermatol.</source>
          <volume>122</volume>
          <year>1990</year>
          <fpage>127</fpage>
          <lpage>136</lpage>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fithian</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Kung</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Rubenfeld</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fenoglio</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Edelson</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Reactivity of Langerhans cells with hybridoma antibody</article-title>
          <source>Proc. Natl. Acad. Sci. U.S.A.</source>
          <volume>78</volume>
          <year>1981</year>
          <fpage>2541</fpage>
          <lpage>2544</lpage>
          <pub-id pub-id-type="pmid">6941307</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gantner</surname>
              <given-names>B.N.</given-names>
            </name>
            <name>
              <surname>Simmons</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Underhill</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Dectin-1 mediates macrophage recognition of <italic>Candida albicans</italic> yeast but not filaments</article-title>
          <source>EMBO J.</source>
          <volume>24</volume>
          <year>2005</year>
          <fpage>1277</fpage>
          <lpage>1286</lpage>
          <pub-id pub-id-type="pmid">15729357</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geijtenbeek</surname>
              <given-names>T.B.</given-names>
            </name>
            <name>
              <surname>Gringhuis</surname>
              <given-names>S.I.</given-names>
            </name>
          </person-group>
          <article-title>Signalling through C-type lectin receptors: shaping immune responses</article-title>
          <source>Nat. Rev. Immunol.</source>
          <volume>9</volume>
          <year>2009</year>
          <fpage>465</fpage>
          <lpage>479</lpage>
          <pub-id pub-id-type="pmid">19521399</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geijtenbeek</surname>
              <given-names>T.B.</given-names>
            </name>
            <name>
              <surname>Torensma</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>van Vliet</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>van Duijnhoven</surname>
              <given-names>G.C.</given-names>
            </name>
            <name>
              <surname>Adema</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>van Kooyk</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Figdor</surname>
              <given-names>C.G.</given-names>
            </name>
          </person-group>
          <article-title>Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses</article-title>
          <source>Cell</source>
          <volume>100</volume>
          <year>2000</year>
          <fpage>575</fpage>
          <lpage>585</lpage>
          <pub-id pub-id-type="pmid">10721994</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Batra</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Bluhm</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Boekhout</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Dawson</surname>
              <given-names>T.L.</given-names>
              <suffix>Jr.</suffix>
            </name>
          </person-group>
          <article-title>Skin diseases associated with <italic>Malassezia</italic> species</article-title>
          <source>J. Am. Acad. Dermatol.</source>
          <volume>51</volume>
          <year>2004</year>
          <fpage>785</fpage>
          <lpage>798</lpage>
          <pub-id pub-id-type="pmid">15523360</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hunger</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Sieling</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Ochoa</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Sugaya</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Burdick</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Rea</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Belisle</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Blauvelt</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Porcelli</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Modlin</surname>
              <given-names>R.L.</given-names>
            </name>
          </person-group>
          <article-title>Langerhans cells utilize CD1a and Langerin to efficiently present nonpeptide antigens to T cells</article-title>
          <source>J. Clin. Invest.</source>
          <volume>113</volume>
          <year>2004</year>
          <fpage>701</fpage>
          <lpage>708</lpage>
          <pub-id pub-id-type="pmid">14991068</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karkowska-Kuleta</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rapala-Kozik</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kozik</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Fungi pathogenic to humans: molecular bases of virulence of <italic>Candida albicans</italic>, <italic>Cryptococcus neoformans</italic> and <italic>Aspergillus fumigatus</italic></article-title>
          <source>Acta Biochim. Pol.</source>
          <volume>56</volume>
          <year>2009</year>
          <fpage>211</fpage>
          <lpage>224</lpage>
          <pub-id pub-id-type="pmid">19543556</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kozubowski</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Heitman</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Signalling pathways in the pathogenesis of Cryptococcus</article-title>
          <source>Cell Microbiol.</source>
          <volume>11</volume>
          <year>2009</year>
          <fpage>370</fpage>
          <lpage>380</lpage>
          <pub-id pub-id-type="pmid">19170685</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McNeil</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Nash</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Hajjeh</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Phelan</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Conn</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Plikaytis</surname>
              <given-names>B.D.</given-names>
            </name>
            <name>
              <surname>Warnock</surname>
              <given-names>D.W.</given-names>
            </name>
          </person-group>
          <article-title>Trends in mortality due to invasive mycotic diseases in the United States, 1980â1997</article-title>
          <source>Clin. Infect. Dis.</source>
          <volume>33</volume>
          <year>2001</year>
          <fpage>641</fpage>
          <lpage>647</lpage>
          <pub-id pub-id-type="pmid">11486286</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mittag</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Fine structural investigation of <italic>Malassezia furfur</italic>. II. The envelope of the yeast cells</article-title>
          <source>Mycoses</source>
          <volume>38</volume>
          <year>1995</year>
          <fpage>13</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">7637677</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Netea</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Kullberg</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Gow</surname>
              <given-names>N.A.R.</given-names>
            </name>
          </person-group>
          <article-title>An integrated model of the recognition of <italic>Candida albicans</italic> by the innate immune system</article-title>
          <source>Nat. Rev. Microbiol.</source>
          <volume>6</volume>
          <year>2008</year>
          <fpage>67</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="pmid">18079743</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pappas</surname>
              <given-names>P.G.</given-names>
            </name>
            <name>
              <surname>Perfect</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Cloud</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Pankey</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Lancaster</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Henderson</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kauffman</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Saccente</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hamill</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Holloway</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Warren</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Dismukes</surname>
              <given-names>W.E.</given-names>
            </name>
          </person-group>
          <article-title>Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy</article-title>
          <source>Clin. Infect. Dis.</source>
          <volume>33</volume>
          <year>2001</year>
          <fpage>690</fpage>
          <lpage>699</lpage>
          <pub-id pub-id-type="pmid">11477526</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pappas</surname>
              <given-names>P.G.</given-names>
            </name>
            <name>
              <surname>Rex</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hamill</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Powderly</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Kauffman</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Hyslop</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Mangino</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Chapman</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Horowitz</surname>
              <given-names>H.W.</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Dismukes</surname>
              <given-names>W.E.</given-names>
            </name>
          </person-group>
          <article-title>A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients</article-title>
          <source>Clin. Infect. Dis.</source>
          <volume>37</volume>
          <year>2003</year>
          <fpage>634</fpage>
          <lpage>643</lpage>
          <pub-id pub-id-type="pmid">12942393</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patterson</surname>
              <given-names>B.K.</given-names>
            </name>
            <name>
              <surname>Landay</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>J.N.</given-names>
            </name>
            <name>
              <surname>Flener</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Pessis</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Chaviano</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>R.C.</given-names>
            </name>
          </person-group>
          <article-title>Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture</article-title>
          <source>Am. J. Pathol.</source>
          <volume>161</volume>
          <year>2002</year>
          <fpage>867</fpage>
          <lpage>873</lpage>
          <pub-id pub-id-type="pmid">12213715</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Richardson</surname>
              <given-names>M.D.</given-names>
            </name>
          </person-group>
          <article-title>Changing patterns and trends in systemic fungal infections</article-title>
          <source>J. Antimicrob. Chemother.</source>
          <volume>56</volume>
          <issue>Suppl. 1</issue>
          <year>2005</year>
          <fpage>i5</fpage>
          <lpage>i11</lpage>
          <pub-id pub-id-type="pmid">16120635</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shibata</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Saitoh</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tadokoro</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Okawa</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>The cell wall galactomannan antigen from <italic>Malassezia furfur</italic> and <italic>Malassezia pachydermatis</italic> contains beta-1,6-linked linear galactofuranosyl residues and its detection has diagnostic potential</article-title>
          <source>Microbiology</source>
          <volume>155</volume>
          <year>2009</year>
          <fpage>3420</fpage>
          <lpage>3429</lpage>
          <pub-id pub-id-type="pmid">19389777</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stambach</surname>
              <given-names>N.S.</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>M.E.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of carbohydrate recognition by Langerin, a C-type lectin of Langerhans cells</article-title>
          <source>Glycobiology</source>
          <volume>13</volume>
          <year>2003</year>
          <fpage>401</fpage>
          <lpage>410</lpage>
          <pub-id pub-id-type="pmid">12626394</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takahara</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Omatsu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yashima</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Iyoda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Clusen</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Letterio</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Steinman</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Inaba</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Identification and expression of mouse Langerin (CD207) in dendritic cells</article-title>
          <source>Int. Immunol.</source>
          <volume>14</volume>
          <year>2002</year>
          <fpage>433</fpage>
          <lpage>444</lpage>
          <pub-id pub-id-type="pmid">11978773</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takahara</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yashima</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Omatsu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>Y.S.</given-names>
            </name>
            <name>
              <surname>Steinman</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>C.G.</given-names>
            </name>
            <name>
              <surname>Inaba</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins</article-title>
          <source>Int. Immunol.</source>
          <volume>16</volume>
          <year>2004</year>
          <fpage>819</fpage>
          <lpage>829</lpage>
          <pub-id pub-id-type="pmid">15096474</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turville</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Arthos</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mac Donald</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Naif</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Cunningham</surname>
              <given-names>A.L.</given-names>
            </name>
          </person-group>
          <article-title>HIV gp120 receptors on human dendritic cells</article-title>
          <source>Blood</source>
          <volume>98</volume>
          <year>2001</year>
          <fpage>2482</fpage>
          <lpage>2488</lpage>
          <pub-id pub-id-type="pmid">11588046</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Valladeau</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ravel</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Dezutter-Dambuyant</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kleijmeer</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Duvert-Frances</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Vincent</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Schmitt</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Davoust</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Caux</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lebecque</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Saeland</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules</article-title>
          <source>Immunity</source>
          <volume>12</volume>
          <year>2000</year>
          <fpage>71</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">10661407</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Valladeau</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zutter-Dambuyant</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Saeland</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Langerin/CD207 sheds light on formation of birbeck granules and their possible function in Langerhans cells</article-title>
          <source>Immunol. Res.</source>
          <volume>28</volume>
          <year>2003</year>
          <fpage>93</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="pmid">14610287</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Kooyk</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Geijtenbeek</surname>
              <given-names>T.B.</given-names>
            </name>
          </person-group>
          <article-title>DC-SIGN: escape mechanism for pathogens</article-title>
          <source>Nat. Rev. Immunol.</source>
          <volume>3</volume>
          <year>2003</year>
          <fpage>697</fpage>
          <lpage>709</lpage>
          <pub-id pub-id-type="pmid">12949494</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vecchiarelli</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Pietrella</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Lupo</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bistoni</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>McFadden</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Casadevall</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>The polysaccharide capsule of <italic>Cryptococcus neoformans</italic> interferes with human dendritic cell maturation and activation</article-title>
          <source>J. Leukoc. Biol.</source>
          <volume>74</volume>
          <year>2003</year>
          <fpage>370</fpage>
          <lpage>378</lpage>
          <pub-id pub-id-type="pmid">12949240</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Saunders</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Grant</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Boekhout</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kuramae</surname>
              <given-names>E.E.</given-names>
            </name>
            <name>
              <surname>Kronstad</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Deangelis</surname>
              <given-names>Y.M.</given-names>
            </name>
            <name>
              <surname>Reeder</surname>
              <given-names>N.L.</given-names>
            </name>
            <name>
              <surname>Johnstone</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Leland</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fieno</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Begley</surname>
              <given-names>W.M.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Lacey</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Chaudhary</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Keough</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sears</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Dawson</surname>
              <given-names>T.L.</given-names>
              <suffix>Jr.</suffix>
            </name>
          </person-group>
          <article-title>Dandruff-associated Malassezia genomes reveal convergent and divergent virulence traits shared with plant and human fungal pathogens</article-title>
          <source>Proc. Natl. Acad. Sci. U.S.A.</source>
          <volume>104</volume>
          <year>2007</year>
          <fpage>18730</fpage>
          <lpage>18735</lpage>
          <pub-id pub-id-type="pmid">18000048</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamasaki</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Matsuzawa</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ishikawa</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Sakuma</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tateno</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Uno</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hirabayashi</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mikami</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Akira</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia</article-title>
          <source>Proc. Natl. Acad. Sci. U.S.A.</source>
          <volume>106</volume>
          <year>2009</year>
          <fpage>1897</fpage>
          <lpage>1902</lpage>
          <pub-id pub-id-type="pmid">19171887</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ack>
      <title>Acknowledgements</title>
      <p>This work was supported by the <funding-source id="gs1">Dutch Scientific Organization (NWO)</funding-source> Grant 91204025 (MdJ) and the <funding-source id="gs2">Wellcome Trust</funding-source> Grant 075565 (MET). We would like to thank Boerhaave Kliniek and Dr. A. Knottenbelt (Flevoziekenhuis) for their valuable support.</p>
    </ack>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>Fig. 1</label>
      <caption>
        <p>Langerin recognizes <italic>Candida</italic> species, <italic>M</italic>. <italic>furfur</italic> and <italic>Saccharomyces</italic> species. (A and B) Yeast strains were coated onto ELISA plates (10<sup>7</sup>/ml) and binding to recombinant Langerin was determined. Polysaccharide mannan was used to determine the specificity of the binding. (C and D) Polysaccharide mannan (C) and <italic>C. albicans</italic> (D) were coated onto ELISA plates at different concentrations. Both mannan and blocking antibody against Langerin (10E2) (<xref rid="bib13" ref-type="bibr">de Witte et al., 2007</xref>) were used to determine specificity. (E) Binding of life and heat-treated <italic>C. albicans</italic> to Langerin. Data represent results from at least three independently performed ELISAs and was performed with two different batches of yeast strains. Error bars represent standard deviation of triplicates.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig. 2</label>
      <caption>
        <p>Titration of a selection of fungi. Yeast strains from <italic>Candida</italic> species (A and B), <italic>Cryptococcus neoformans</italic> (C), <italic>Cryptococcus gattii</italic> (D), and <italic>Saccharomyces cerevisiae</italic> (E) were coated onto ELISA plates at different concentrations. Mannan was used to determine specificity. Data are representative of at least three independent experiments. Error bars represent standard deviation of triplicates.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Fig. 3</label>
      <caption>
        <p>Langerin is a receptor for Î²-glucans. (A) Langerin specifically interacts with mannose, fucose and GlcNAc structures. Carbohydrate binding to Langerin was determined by recombinant Langerin ELISA. Specificity was determined by mannan, anti-Langerin (10E2) (<xref rid="bib13" ref-type="bibr">de Witte et al., 2007</xref>) or isotype control antibodies. (BâF) Langerin is a receptor for Î²-glucans present on curdlan, laminarin and zymosan. Mannan (C), zymosan (D), laminarin (E) and curdlan (F) were coated onto ELISA plates in different concentrations. Binding to Langerin was inhibited by addition of mannan or laminarin. Data represent results from at least three independent experiments. Error bars represent standard deviation of triplicates.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Fig. 4</label>
      <caption>
        <p><italic>Candida</italic> species and zymosan interact with cellular Langerin. (A) Langerin and dectin-1 expression on Jurkat cell-line transduced with Langerin. Thin line represents isotype control, filled histogram represents specific staining. (B) Langerin expressing cell-line was incubated with different concentrations of FITC-labelled fungi and binding was measured by flow-cytometric analysis. Pre-incubation with mannan was used to determine specificity. Data represent results from at least three independent experiments. Error bars represent standard deviation of triplicates.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="fig5">
      <label>Fig. 5</label>
      <caption>
        <p>Langerin is the primary receptor for fungi on LCs. (A) CD1a, Langerin, dectin-1 and DC-SIGN expression on primary immature LCs. Thin line represents isotype control, filled histogram represents specific staining. (B) Binding of different fungi to human LCs was investigated. FITC-labelled fungi were incubated with LCs at MOI 10. Specificity was determined by mannan, blocking antibodies against Langerin and dectin-1, or isotype controls. Binding was measured by flow cytometry. Data represent results from at least three different donors. Error bars represent standard deviation of triplicates.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <fig id="fig6">
      <label>Fig. 6</label>
      <caption>
        <p>Electron microscopic analysis of <italic>Candida albicans</italic> interaction with LCs. (A) Electron microscopic picture of LCs which has internalized <italic>C. albicans</italic> (C). Arrow is directed towards <italic>C. albicans</italic>. (BâD) Gold labelling of Langerin demonstrates Langerin localization at the binding site of LCs and <italic>C. albicans</italic>. Arrows are directed towards Langerin gold labelling. Picture (B) is a magnification of (A), and (D) is a magnification of (C).</p>
      </caption>
      <graphic xlink:href="gr6"/>
    </fig>
    <table-wrap id="tbl1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Yeast strains and CBS numbers.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">Strain</th>
            <th align="left">CBS no.</th>
            <th align="left">No.</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">
              <italic>Candida albicans</italic>
            </td>
            <td align="left">CBS 8781</td>
            <td align="left">1</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. albicans</italic>
            </td>
            <td align="left">CBS 562</td>
            <td align="left">2</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. albicans</italic>
            </td>
            <td align="left">CBS 8758</td>
            <td align="left">3</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. albicans</italic>
            </td>
            <td align="left">CBS 1912</td>
            <td align="left">4</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. albicans</italic>
            </td>
            <td align="left">CBS 2712</td>
            <td align="left">5</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. albicans</italic>
            </td>
            <td align="left">CBS 5144</td>
            <td align="left">6</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. dubliniensis</italic>
            </td>
            <td align="left">CBS 8501</td>
            <td align="left">7</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. dubliniensis</italic>
            </td>
            <td align="left">CBS 8500</td>
            <td align="left">8</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. glabrata</italic>
            </td>
            <td align="left">CBS 138</td>
            <td align="left">9</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. glabrata</italic>
            </td>
            <td align="left">CBS 860</td>
            <td align="left">10</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. guilliermondii</italic>
            </td>
            <td align="left">CBS 566</td>
            <td align="left">11</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. guilliermondii</italic>
            </td>
            <td align="left">CBS 2031</td>
            <td align="left">12</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. krusei</italic>
            </td>
            <td align="left">CBS 573</td>
            <td align="left">13</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. parapsilosis</italic>
            </td>
            <td align="left">CBS 604</td>
            <td align="left">14</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. parapsilosis</italic>
            </td>
            <td align="left">CBS 2195</td>
            <td align="left">15</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. tropicalis</italic>
            </td>
            <td align="left">CBS 94</td>
            <td align="left">16</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. tropicalis</italic>
            </td>
            <td align="left">CBS 1920</td>
            <td align="left">17</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. lusitaniae</italic>
            </td>
            <td align="left">CBS 4413</td>
            <td align="left">18</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. lusitaniae</italic>
            </td>
            <td align="left">CBS 4414</td>
            <td align="left">19</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. nivariensis</italic>
            </td>
            <td align="left">CBS 9983</td>
            <td align="left">20</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. nivariensis</italic>
            </td>
            <td align="left">CBS 9985</td>
            <td align="left">21</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. orthopsilosis</italic>
            </td>
            <td align="left">CBS 10741</td>
            <td align="left">22</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. orthopsilosis</italic>
            </td>
            <td align="left">CBS 10906</td>
            <td align="left">23</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. metapsilosis</italic>
            </td>
            <td align="left">CBS 10746</td>
            <td align="left">24</td>
          </tr>
          <tr>
            <td align="left">
              <italic>C. metapsilosis</italic>
            </td>
            <td align="left">CBS 10747</td>
            <td align="left">25</td>
          </tr>
          <tr>
            <td align="left">
              <italic>Malassezia furfur</italic>
            </td>
            <td align="left">CBS 1878</td>
            <td align="left">26</td>
          </tr>
          <tr>
            <td align="left"><italic>Cryptococcus neoformans variety grubii</italic> serotype A</td>
            <td align="left">CBS 10085</td>
            <td align="left">27</td>
          </tr>
          <tr>
            <td align="left"><italic>Cr. neoformans variety grubii</italic> serotype A</td>
            <td align="left">CBS 10083</td>
            <td align="left">28</td>
          </tr>
          <tr>
            <td align="left"><italic>Cr. neoformans variety neoformans</italic> serotype D</td>
            <td align="left">CBS 10079</td>
            <td align="left">29</td>
          </tr>
          <tr>
            <td align="left"><italic>Cr. neoformans variety neoformans</italic> serotype D (acapsular)</td>
            <td align="left">CBS 7935</td>
            <td align="left">30</td>
          </tr>
          <tr>
            <td align="left"><italic>Cr. neoformans variety neoformans</italic> serotype AD hybrid</td>
            <td align="left">CBS 10080</td>
            <td align="left">31</td>
          </tr>
          <tr>
            <td align="left"><italic>Cr. gattii</italic> serotype B</td>
            <td align="left">CBS 10078</td>
            <td align="left">32</td>
          </tr>
          <tr>
            <td align="left"><italic>Cr. gattii</italic> serotype C</td>
            <td align="left">CBS 10081</td>
            <td align="left">33</td>
          </tr>
          <tr>
            <td align="left"><italic>Cr. gattii</italic> serotype B</td>
            <td align="left">CBS 10082</td>
            <td align="left">34</td>
          </tr>
          <tr>
            <td align="left"><italic>Cr. gattii</italic> serotype C</td>
            <td align="left">CBS 10101</td>
            <td align="left">35</td>
          </tr>
          <tr>
            <td align="left"><italic>Cr. gattii</italic> serotype B</td>
            <td align="left">CBS 11687</td>
            <td align="left">36</td>
          </tr>
          <tr>
            <td align="left"><italic>Cr. neoformans</italic>Â ÃÂ <italic>Cr. gattii</italic> serotype BD hybrid</td>
            <td align="left">CBS 10488</td>
            <td align="left">37</td>
          </tr>
          <tr>
            <td align="left"><italic>Cr. neoformans</italic>Â ÃÂ <italic>Cr. gattii</italic> serotype AB hybrid</td>
            <td align="left">CBS 10496</td>
            <td align="left">38</td>
          </tr>
          <tr>
            <td align="left"><italic>Saccharomyces cerevisiae</italic> (virulent)</td>
            <td align="left">CBS 7837</td>
            <td align="left">39</td>
          </tr>
          <tr>
            <td align="left"><italic>Saccharomyces cerevisiae</italic> (avirulent, genome sequenced strain)</td>
            <td align="left">CBS 8803</td>
            <td align="left">40</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>